- Hikma Pharmaceuticals said it had launched an injectable antibiotic treatment in the US.

Vancomycin Hydrochloride was an an essential antibiotic used by hospitals to treat patients who have failed to respond to a number of other antibiotics, the company said.

Its launched marked Hikma's 100th injectable medicine into the US market.

'This launch marks a great milestone - Hikma's 100th injectable medicine and it demonstrates our commitment to providing doctors and hospitals with a broad range of high-quality medicines needed to treat the current and future needs of patients,' executive vice president, commercial and development Dan Motto said.

At 1:28pm: [LON:HIK] Hikma Pharmaceuticals PLC share price was +3p at 1768.5p

Story provided by